PLAQUE CLAIMS ARE DRUG CLAIMS
This article was originally published in The Tan Sheet
Executive Summary
PLAQUE CLAIMS ARE DRUG CLAIMS, FDA's OTC Plaque Subcommittee decided in a 4-2 vote on Dec. 7. The recommendation voted on by the subcommittee states that in classifying OTC plaque products, "all references to the control of dental plaque, or its equivalents, with or without qualification, will be interpreted as a drug claim."